MRI in medium-chain acyl-coenzyme a dehydrogenase deficiency: Neuroimaging during the first month

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Medium-chain acyl-coenzyme A dehydrogenase (MCAD) is the most common genetic disorder of fatty acid oxidation, which presents before the age of 2 with the onset of acute hypoketotic hypoglycemia, and is typically precipitated by stress. We report serial brain magnetic resonance imaging (MRI) changes, including MR spectroscopy (MRS) and diffusion weighted imaging (DWI), in a patient with a classical MCAD presentation, compared with five healthy controls. Through this unique case we analyze the evolution of radiological findings during the first month of illness and we highlight the pivotal role of MRI, especially DWI, in the early diagnosis of the decompensated state of the disease.

Cite

CITATION STYLE

APA

Talamanca, L. F., Pasquini, L., Napolitano, A., & Longo, D. (2017). MRI in medium-chain acyl-coenzyme a dehydrogenase deficiency: Neuroimaging during the first month. Journal of Pediatric Endocrinology and Metabolism, 30(8), 905–908. https://doi.org/10.1515/jpem-2017-0045

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free